ID
44443
Description
Study part: Vital Signs (VS) Screening. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Keywords
Versions (2)
- 6/10/18 6/10/18 -
- 9/20/21 9/20/21 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Vital Signs (VS) Screening Pazopanib Macular Degeneration MD1103367
Vital Signs (VS) Screening
- StudyEvent: ODM
Description
MEASUREMENT
Alias
- UMLS CUI-1
- C2963216
Description
Vital signs measurements Body position
Data type
text
Alias
- UMLS CUI [1,1]
- C2963216
- UMLS CUI [1,2]
- C1262869
Description
Actual time
Data type
time
Alias
- UMLS CUI [1]
- C0040223
Description
Subject position
Data type
integer
Alias
- UMLS CUI [1,1]
- C1262869
- UMLS CUI [1,2]
- C0518766
Description
Blood pressure systolic
Data type
integer
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Description
Blood pressure diastolic
Data type
integer
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Description
Heart rate
Data type
integer
Measurement units
- beats/min
Alias
- UMLS CUI [1]
- C0018810
Similar models
Vital Signs (VS) Screening
- StudyEvent: ODM
C0038846 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
C1262869 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
No comments